Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation

Kangdong Liu, Yong Yeon Cho, Ke Yao, Janos Nadas, Dong Joon Kim, Eun Jin Cho, Mee Hyun Lee, Angelo Pugliese, Jishuai Zhang, Ann M. Bode, Ziming Dong, Zigang Dong

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds